Lunai Bioworks Inc. Common Stock
Symbol: RENB (NASDAQ)
0.00
▼ (-100.00%) -1.420
Company Description:
Lunai Bioworks Inc is a biopharmaceutical company. It is engaged in developing new immunotherapies to combat cancer and developing a predicative artificial intelligence-based diagnostic methodology for the use of earlier cancer detection.
Key Stats
- Today's Open: $0
- Today's High: $0
- Today's Low: $0
- Today's Volume: 0
- Yesterday Close: $1.42
- Yesterday High: $1.43
- Yesterday Low: $1.13
- Yesterday Volume: 896.30K
- Last Min Volume: 0
- Last Min High: $0
- Last Min Low: $0
- Last Min VWAP: $0
Company Profile
- Name: Lunai Bioworks Inc. Common Stock
- Website: https://www.renovarogroup.com
- Listed Date: 2014-11-18
- Location: SUITE 906 LOS ANGELES, CA
- Market Status: Active
- CIK Number: 0001527728
- SIC Code: 2834
- SIC description: PHARMACEUTICAL PREPARATIONS
- Market Cap: $32.92M
- Round Lot: 100
- Outstanding Shares: 23.18M
- Asset Type: CS
RECENT FILINGS FOR RENB
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-09-29 | 10-K | View |
| 2025-09-26 | SCHEDULE 13G | View |
| 2025-09-24 | 8-K | View |
| 2025-09-05 | 8-K | View |
| 2025-08-26 | 8-K | View |
| 2025-08-06 | 8-K | View |
| 2025-07-30 | DEF 14A | View |
| 2025-07-25 | 8-K | View |
| 2025-07-18 | PRE 14A | View |
| 2025-07-14 | 8-K | View |
| 2025-07-10 | SCHEDULE 13D/A | View |
| 2025-07-09 | 8-K | View |
| 2025-06-05 | 8-K | View |
| 2025-05-15 | 10-Q | View |
| 2025-04-18 | 8-K | View |
| 2025-04-14 | SCHEDULE 13D/A | View |
| 2025-04-10 | 8-K | View |
| 2025-03-12 | 4 | View |
| 2025-03-06 | 425 | View |
| 2025-03-06 | 8-K | View |
Latest News on RENB